Glen Y. Sato

Glen Y. Sato is a partner in the Life Sciences and Securities Regulation practice groups and a member of Cooley's Business department. He rejoined the Firm in 2006 and is resident in the Palo Alto office.

Mr. Sato's practice focuses on corporate transactions, SEC reporting and compliance, disclosure issues, intellectual property licensing and licensing strategy, general corporate counseling, insider trading compliance and working with Boards of Directors and audit committees on various risks and accounting related matters. Together with strong finance capabilities, Sato also has substantial experience in corporate partnering, international and domestic M&A and other heavily negotiated transactions. He has worked closely with underwriters on public and private company acquisitions and led successful initial public, follow-on and secondary, and convertible note offerings. He has also led or been significantly involved in corporate partnering, licensing and product acquisition transactions involving leading pharmaceutical and biotechnology companies such as Abaxis, AcelRx, Abbott, Anacor, AstraZeneca, Bayer, BiogenIdec, Boehringer Ingelheim, Bristol-Myers Squibb, Exelixis, Eli Lilly, Genentech, GlaxoSmithKline, Jazz Pharmaceuticals, Johnson & Johnson, Merck, Novartis, PDL BioPharma, Pfizer, Roche and Sandoz.

Prior to joining the Firm, Mr. Sato served in diverse legal, financial, operational and strategic planning positions where his responsibilities included finance, business development, IS, HR, and Facilities. He most recently served as Protein Design Labs' (PDL) Senior Vice President and Chief Financial Officer. He joined PDL from Exelixis, Inc., where he served as SVP, Chief Financial Officer and General Counsel for approximately three years. Prior to his time at Exelixis, he served in various legal and strategic planning positions at PDL, including Vice President, Legal and General Counsel.

Mr. Sato has been recognized in the Best Lawyers in America 2014 and 2015 editions for Biotechnology Law.

Mr. Sato received his JD and MBA from UCLA in 1987, where he was an Associate Editor of the Law Review. He received a Bachelor's degree in Economics and the College of Social Studies in 1981 from Wesleyan University.

Mr. Sato is a member of the State Bar of California and an inactive member of the Washington, DC Bar Association.

Good to know

Areas of Practice 1) Medical Devices, 2) Life Sciences, 3) Mergers & Acquisitions, 4) Public Companies, 5) Life Sciences Corporate Partnering & Licensing and 6) Cross-Border Mergers & Acquisitions
Law School UCLA School of Law, J.D.,1987
Education Wesleyan University, B.A.,1981
Bar Member / Association California State Bar Association
Most recent firm Cooley LLP
Relevant Jobs
Probate Trust Admin Paralegal

Employment Type Part-Time Job Title: Probate-Trust Admin Paralegal Company Jack L Collison, A Professional Law Corporation Location: Solvang, CA 93463 Salary: DOE Hours: Position is ...

Apply now

Seasoned Corporate Reorganization Paralegal
USA-CA-Los Angeles

Looking for a seasoned paralegal / attorney who can work on a one-time contract.  Prefer someone who has tax / corporate reorganization experience.  

Apply now

Mid-Level Commercial Litigation Attorney
USA-CA-San Diego

Contract to Hire (Hourly Part Time with opportunity to shift to full time) Our San Diego-based boutique business law firm is seeking a mid-level litigation attorney with 2-3 years litigation experi...

Apply now

+ View more jobs
Alan Singer
Alan Singer

Alan Singer is a partner in Morgan Lewis's Securities Practice. Mr. Singer advises companies with regard to a diverse range of corporate and securities matters.

Barbara A. Fitzgerald
Barbara A. Fitzgerald

Ms. Fitzgerald represents employers in a wide range of industries, including the entertainment, financial services, hospitality, manufacturing, retail, and transportation industries.

Barbara J. Shander
Barbara J. Shander

Ms. Shander advises public and private company clients as well as private equity funds, with an emphasis on mergers and acquisitions, dispositions, and financing transactions.